Navigation Links
Treating rare breast cancer with radiation therapy may lower recurrence rate
Date:7/11/2008

Patients with a rare type of breast cancer may benefit from receiving radiation therapy in addition to surgery to prevent recurrence, according to a study in the July issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

Phyllodes tumors are rare breast tumors that develop in the connective tissue of the breast, as opposed to more common carcinomas, which develop in the ducts or lobules of the breast. Most patients are treated for phyllodes tumors with either a lumpectomy or mastectomy, with only a small fraction of patients receiving radiation therapy.

Traditionally, adjuvant radiation therapy is recommended for cancer patients with local recurrence risks of 15 percent or greater, but the value of adjuvant radiation therapy has not been extensively studied for phyllodes tumors because they are so rare.

Researchers at the Division of Radiation Oncology, Department of Medical Physics, and Department of General and Oncologic Surgery at City of Hope National Medical Center in Duarte, Calif., sought to determine the local recurrence rates of phyllodes tumors based on tumor size and the type of surgery performed and whether adjuvant radiation therapy should be considered as a treatment for some phyllodes tumor patients to reduce their local recurrence rate.

"Typically these tumors are treated well by surgery alone. However, local recurrences are not uncommon," Richard Pezner, M.D., lead author of the study and a radiation oncologist at City of Hope National Medical Center in Duarte, Calif., said.

The study authors reviewed records of 478 patients with malignant phyllodes tumors who were treated between March 1964 and August 2005. The records came from the IMPAC National Oncology Database, which consists of tumor registries from 130 hospitals.

The researchers found that the risk of local recurrence for phyllodes tumors was related to tumor size and the type of surgery received. They determined that adjuvant radiation therapy should be evaluated for phyllodes tumor patients who received lumpectomies for tumors at least 2 centimeters in size or a mastectomy for tumors at least 10 centimeters in size to reduce the risk of recurrence.


'/>"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Therapeutic Radiology and Oncology
Source:Eurekalert

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... KS (PRWEB) , ... January 24, 2017 , ... ... Premensa, a leading natural supplement for relieving premenstrual syndrome, or PMS . ... at some point. These symptoms can include cramps, constipation, irritability, headaches, fatigue, and ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Mysteries Revealed On Speaking In Tongues”: ... is available to all Christians. “Mysteries Revealed On Speaking In Tongues” is the creation ... a Christian-based talk show located in Michigan. , “We need to partner with ...
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and Medically Underserved ... bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. The ... Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for their ...
(Date:1/24/2017)... ... January 23, 2017 , ... The ... Buzzies users who entered metrics into the product’s app. The data replicates ... data showed that within just 30 seconds of using Buzzies, people experienced a ...
(Date:1/23/2017)... ... 23, 2017 , ... PKF O’Connor Davies , LLP, the nation’s 26th ... at the Firm, will participate in the 40th Annual "Empire State Building Run Up" ... up 1,576 steps, a vertical distance equal to about a fifth of a mile, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Jan. 23, 2017 LifeVac, the revolutionary device ... airway and prevented choking deaths, welcomes Steve Way ... the LifeVac team as Official Spokesperson. ... LifeVac team," said Arthur Lih , Founder and ... LifeVac and his mission to raise awareness about the ...
(Date:1/23/2017)... 23, 2017 Research and Markets has announced the ... - Product - Forecast to 2025" report to their offering. ... Report Highlights: ... trends to identify the investment opportunities Market forecasts till ... Key market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... January 23, 2017 Stock-Callers.com today presents ... (NASDAQ: CPRX ), Sophiris Bio Inc. (NASDAQ: ... ), and Agile Therapeutics Inc. (NASDAQ: AGRX ). ... somewhat lower in late trade on Friday, January 20 th ... 0.3%, while shares of health care companies in the S&P ...
Breaking Medicine Technology: